Genetic heterogeneity in breast cancer: the road to personalised medicine?
Baird, Richard D.
MetadataShow full item record
Baird, R. D., & Caldas, C. (2013). Genetic heterogeneity in breast cancer: the road to personalised medicine?. BMC Medicine, 11 151. https://doi.org/10.1186/1741-7015-11-151
This is the final published version. It was originally published here: http://www.biomedcentral.com/1741-7015/11/151. DOI: 10.1186/1741-7015-11-151.
More women die from breast cancer across the world today than from any other type of malignancy. The clinical course of breast cancer varies tremendously between patients. While some of this variability is explained by traditional clinico-pathological factors (including patient age, tumor stage, histological grade and estrogen receptor status), molecular profiling studies have defined breast cancer subtypes with distinct clinical outcomes. This mini-review considers recent studies which have used genomics technologies in an attempt to identify new biomarkers of prognosis and treatment response. These studies highlight the genetic heterogeneity that exists within breast cancers in space and time.
External DOI: https://doi.org/10.1186/1741-7015-11-151
This record's URL: https://www.repository.cam.ac.uk/handle/1810/245718
Attribution 2.0 UK: England & Wales
Licence URL: http://creativecommons.org/licenses/by/2.0/uk/
Recommended or similar items
The following licence files are associated with this item: